Advances in immunotherapy for triple-negative breast cancer
The diagram of combination of ICIs and other treatment. Anthracyclines, taxanes, cisplatin, doxorubicin and Albumin-PTX, and eribulin are used to combine with ICIs to enhance the clinical response in early and metastatic TNBC. Low-dose RT with Nivolumab and RT with Pembrolizumab enhance anti-tumor efficacy in TNBC. The Ad.sT interfered with TGF β-1 binding and improved the immunotherapeutic effect of ICIs. The regimen of adenovirus-mediated HSV thymidine kinase, SBRT, and pembrolizumab improve the therapeutic efficacy in patients with mTNBC, PARPIs upregulate IFN responses through the cGAS-cGAMP-STING pathway to upregulate PD-L1 expression. Low doses of VEGFR2 antibodies provoke CD8 + T cells and macrophages to secrete OPN and promote the production of TGF-β which upregulates the expression of PD-1. PI3K-γ inhibitor eganelisib (IPI-549) and PTX enhanced the efficacy of α-PD1 in TNBC. 2 F-Fuc enhances the activation of T cells by reducing B7H3 glycosylation and restoring the susceptibility of tumor cells to enhance PD-L1 efficacy. Olaparib, Ipatasertib, cobimetinib, entinostat, ladiratuzumab vedotin, and trastuzumab deruxtecan combined with ICIs and chemo drugs has demonstrated favorable efficacy in managing TNBC. The combining anti-PD-1 therapy with iPPO and MW offers an effective tumor growth inhibition effect. in a study. In combination with anti-PD-L1 therapy, mEHGZ effectively induced IFN-γ positivity in TNBC. The combination treatment with the CTLA-4 and MUC1 messenger RNA nanomachines is associated with lower expression of IL-6 and TNF-α, which may reshape the immunosuppressive TME
Publication
Advances in immunotherapy for triple-negative breast cancer. (2023) Yang Liu, et al. Mol Cancer. 2023;22:145. Figure: F4.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Drosophila melanogaster | Invertebrates | -STING | STING | ncbigene_symbol | Sting | 36016 |
| Drosophila melanogaster | Invertebrates | -STING | STING | ncbigene_synonym | aub | 34524 |
| Drosophila melanogaster | Invertebrates | PI3KI | PI3KI | ncbigene_synonym | Pi3K92E | 42446 |
| Drosophila melanogaster | Invertebrates | PTX | PTX | ncbigene_synonym | Ptx1 | 43664 |
| Drosophila melanogaster | Invertebrates | TGF-B | TGF-B | ncbigene_synonym | dpp | 33432 |
| Drosophila melanogaster | Invertebrates | TGF-B | TGF-B | ncbigene_synonym | gbb | 37778 |
| Drosophila melanogaster | Invertebrates | TGF-B | TGF-B | ncbigene_synonym | put | 41772 |
| Drosophila melanogaster | Invertebrates | TGF-B | TGF-B | ncbigene_synonym | mav | 43804 |
| Drosophila melanogaster | Invertebrates | ST | ST | ncbigene_symbol | st | 39836 |
| Drosophila melanogaster | Invertebrates | Ad. | AD | ncbigene_symbol | ad | 247742 |
| Drosophila melanogaster | Invertebrates | MW | MW | ncbigene_symbol | mw | 44841 |
| Drosophila melanogaster | Invertebrates | TNF-a | TNF-A | ncbigene_synonym | egr | 36054 |
| Drosophila melanogaster | Invertebrates | Low | LOW | ncbigene_symbol | Low | 44325 |
| Drosophila melanogaster | Invertebrates | RT | RT | ncbigene_symbol | rt | 39297 |
| Homo sapiens | Primates | CGAS- | CGAS | ncbigene_symbol | CGAS | 115004 |
| Homo sapiens | Primates | -STING | STING | ncbigene_synonym | STING1 | 340061 |
| Homo sapiens | Primates | IFN | IFN | ncbigene_synonym | IFNA1 | 3439 |
| Homo sapiens | Primates | OPN | OPN | ncbigene_synonym | SPP1 | 6696 |
| Homo sapiens | Primates | TGF-B | TGFB | ncbigene_synonym | TGFB1 | 7040 |
| Homo sapiens | Primates | TGF-B | TGFB | famplex_relations | TGFB2 | 7042 |
| Homo sapiens | Primates | TGF-B | TGFB | famplex_relations | TGFB3 | 7043 |
| Homo sapiens | Primates | ICIS | ICIS | ncbigene_synonym | MTUS2 | 23281 |
| Homo sapiens | Primates | ICIS | ICIS | ncbigene_synonym | MTUS1 | 57509 |
| Homo sapiens | Primates | B7H3 | B7H3 | ncbigene_synonym | CD276 | 80381 |
| Homo sapiens | Primates | MUC1 | MUC1 | ncbigene_symbol | MUC1 | 4582 |
| Homo sapiens | Primates | CTLA4 | CTLA4 | ncbigene_symbol | CTLA4 | 1493 |
| Homo sapiens | Primates | TNF-a | TNF-A | ncbigene_synonym | TNF | 7124 |
| Homo sapiens | Primates | IL-6 | IL-6 | ncbigene_synonym | IL6 | 3569 |
| Word | Match | MeSH | Name | ChEBI |
|---|---|---|---|---|
| thymidine | Thymidine | mesh:D013936 | thymidine | chebi:17748 |
| Anthracyclines | anthracycline | mesh:D018943 | Anthracyclines | chebi:48120 |
| Taxanes | taxane | mesh:C080625 | taxane | chebi:36064 |
| Doxorubicin | Doxorubicin | mesh:D004317 | doxorubicin | chebi:28748 |
| PTX | NA | mesh:C051905 | ||
| Cisplatin | Cisplatin | mesh:D002945 | cisplatin | chebi:27899 |
| IPPO | NA | mesh:C478180 | ||
| MEHG2 | NA | mesh:C021591 | ||
| Cobimetinib | NA | mesh:C574276 | ||
| Atezolimuzab | NA | |||
| Paclitaxel | Paclitaxel | mesh:D017239 | paclitaxel | chebi:45863 |
| Entinostat | entinostat | mesh:C118739 | entinostat | chebi:132082 |
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|